A detailed history of Generali Asset Management Spa Sgr transactions in Incyte Corp stock. As of the latest transaction made, Generali Asset Management Spa Sgr holds 30,934 shares of INCY stock, worth $2.42 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
30,934
Previous 15,991 93.45%
Holding current value
$2.42 Million
Previous $968 Million 117.57%
% of portfolio
0.05%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025

BUY
$55.17 - $71.22 $824,405 - $1.06 Million
14,943 Added 93.45%
30,934 $2.11 Billion
Q1 2025

May 15, 2025

SELL
$60.0 - $75.26 $1.35 Million - $1.69 Million
-22,496 Reduced 58.45%
15,991 $968 Million
Q4 2024

May 29, 2025

BUY
$65.08 - $83.38 $1.46 Million - $1.88 Million
22,496 Added 140.68%
38,487 $2.66 Billion
Q4 2024

Feb 10, 2025

BUY
$65.08 - $83.38 $2.5 Million - $3.21 Million
38,487 New
38,487 $2.66 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $17.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Generali Asset Management Spa Sgr Portfolio

Follow Generali Asset Management Spa Sgr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Generali Asset Management Spa Sgr, based on Form 13F filings with the SEC.

News

Stay updated on Generali Asset Management Spa Sgr with notifications on news.